What is a stock summary page? Click here for an overview.
Business Description
Arcadia Biosciences Inc
NAICS : 311999
SIC : 2099
ISIN : US0390142042
Compare
Compare
Traded in other countries / regions
RKDA.USA17D.Germany IPO Date
2015-05-15Description
Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water and others.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 27.37 | |||||
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -28.98 | |||||
| Beneish M-Score | 1.95 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -33.8 | |||||
| 3-Year EBITDA Growth Rate | 52.7 | |||||
| 3-Year EPS without NRI Growth Rate | 47.6 | |||||
| 3-Year FCF Growth Rate | 48.1 | |||||
| 3-Year Book Growth Rate | -56.7 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.12 | |||||
| 9-Day RSI | 32.67 | |||||
| 14-Day RSI | 32.85 | |||||
| 3-1 Month Momentum % | -36.01 | |||||
| 6-1 Month Momentum % | 43.75 | |||||
| 12-1 Month Momentum % | 76.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.61 | |||||
| Quick Ratio | 3.25 | |||||
| Cash Ratio | 1.66 | |||||
| Days Inventory | 118.69 | |||||
| Days Sales Outstanding | 57.19 | |||||
| Days Payable | 136.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -35 | |||||
| Shareholder Yield % | 22.69 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.67 | |||||
| Operating Margin % | -170.96 | |||||
| Net Margin % | -132.44 | |||||
| FCF Margin % | -181.46 | |||||
| ROE % | -68.1 | |||||
| ROA % | -42.98 | |||||
| ROIC % | -134.6 | |||||
| 3-Year ROIIC % | -480.92 | |||||
| ROC (Joel Greenblatt) % | -744.31 | |||||
| ROCE % | -66.98 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.76 | |||||
| PB Ratio | 0.65 | |||||
| Price-to-Tangible-Book | 0.66 | |||||
| EV-to-EBIT | -0.06 | |||||
| EV-to-EBITDA | -0.06 | |||||
| EV-to-Revenue | 0.1 | |||||
| EV-to-Forward-Revenue | 0.34 | |||||
| EV-to-FCF | -0.06 | |||||
| Price-to-GF-Value | 1 | |||||
| Price-to-Median-PS-Value | 0.16 | |||||
| Price-to-Net-Current-Asset-Value | 2.08 | |||||
| Earnings Yield (Greenblatt) % | -1666.67 | |||||
| FCF Yield % | -237.86 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RKDA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arcadia Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 5.314 | ||
| EPS (TTM) ($) | -5.17 | ||
| Beta | 0.38 | ||
| 3-Year Sharpe Ratio | -0.37 | ||
| 3-Year Sortino Ratio | -0.64 | ||
| Volatility % | 141.49 | ||
| 14-Day RSI | 32.85 | ||
| 14-Day ATR ($) | 0.23665 | ||
| 20-Day SMA ($) | 3.366325 | ||
| 12-1 Month Momentum % | 76.92 | ||
| 52-Week Range ($) | 1.8512 - 10.3099 | ||
| Shares Outstanding (Mil) | 1.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Arcadia Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Arcadia Biosciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Arcadia Biosciences Inc Frequently Asked Questions
What is Arcadia Biosciences Inc(RKDA)'s stock price today?
The current price of RKDA is $2.97. The 52 week high of RKDA is $10.31 and 52 week low is $1.85.
When is next earnings date of Arcadia Biosciences Inc(RKDA)?
The next earnings date of Arcadia Biosciences Inc(RKDA) is 2025-05-09 Est..
Does Arcadia Biosciences Inc(RKDA) pay dividends? If so, how much?
Arcadia Biosciences Inc(RKDA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers